Ascopiave S.p.A. (LON:0DME)
3.055
+0.115 (3.93%)
At close: Apr 11, 2025
Ascopiave Revenue
In the year 2024, Ascopiave had annual revenue of 204.96M EUR with 13.37% growth. Ascopiave had revenue of 58.67M in the quarter ending December 31, 2024, with 5.44% growth.
Revenue
204.96M EUR
Revenue Growth
+13.37%
P/S Ratio
3.57
Revenue / Employee
414.06K EUR
Employees
495
Market Cap
604.79M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 204.96M | 24.16M | 13.37% |
Dec 31, 2023 | 180.79M | 17.14M | 10.48% |
Dec 31, 2022 | 163.65M | 28.74M | 21.30% |
Dec 31, 2021 | 134.91M | -28.99M | -17.69% |
Dec 31, 2020 | 163.90M | 38.99M | 31.21% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
HSBC Holdings | 48.93B |
Shell | 227.10B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |